Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.26B | 14.46B | 13.80B | 13.74B | 15.01B | 15.35B | Gross Profit |
1.47B | 1.46B | 1.42B | 1.74B | 2.25B | 2.35B | EBIT |
660.00M | 677.00M | 586.00M | 892.00M | 1.36B | 1.39B | EBITDA |
1.17B | 1.41B | 1.19B | 1.43B | 1.94B | 2.03B | Net Income Common Stockholders |
543.00M | 553.00M | 459.00M | 683.00M | 1.01B | 990.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.86B | 2.55B | 6.45B | 9.50B | 9.45B | 8.62B | Total Assets |
25.39B | 25.75B | 24.87B | 24.53B | 24.48B | 23.85B | Total Debt |
1.00M | 1.00M | 2.00M | 3.00M | 5.00M | 5.00M | Net Debt |
-3.85B | -2.55B | -6.45B | -9.50B | -9.45B | -8.61B | Total Liabilities |
2.99B | 3.25B | 2.71B | 2.88B | 3.30B | 3.36B | Stockholders Equity |
22.39B | 22.50B | 22.16B | 21.65B | 21.18B | 20.49B |
Cash Flow | Free Cash Flow | ||||
0.00 | -3.62B | -2.85B | 327.00M | 1.11B | 1.79B | Operating Cash Flow |
0.00 | 1.41B | 914.00M | 1.06B | 1.43B | 2.02B | Investing Cash Flow |
0.00 | -4.12B | -4.39B | -733.00M | -320.00M | -239.00M | Financing Cash Flow |
0.00 | -278.00M | -278.00M | -277.00M | -277.00M | -277.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥15.11B | 16.13 | 1.89% | 5.15% | -13.31% | ||
75 Outperform | ¥16.08B | 10.53 | 3.36% | -5.97% | -37.27% | ||
71 Outperform | ¥14.05B | 15.16 | 1.70% | 4.25% | -18.59% | ||
65 Neutral | $8.92B | 15.03 | 4.68% | 6.11% | 3.59% | -2.49% | |
64 Neutral | ¥14.43B | 17.26 | 1.53% | 0.59% | -15.61% | ||
61 Neutral | ¥14.30B | 25.86 | 1.94% | 4.72% | 20.48% | ||
56 Neutral | ¥13.91B | 26.10 | 0.30% | -2.04% | ― |